ESR1 and invasive lobular breast carcinoma: FMO2, located within the candidate gains on 1q and is known to be overexpressed in invasive lobular carcinoma relative to invasive ductal carcinoma, which was consistent with our results, with genetic subgroups differed with regard to histology, tumor grading, frequency of alterations, and ER expression [32].